Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Radiation Oncology
•
Medical Oncology
•
Lymphoma
•
Hematology
What is the role of radiation consolidation after chemotherapy for residual splenic involvement in follicular lymphoma?
Answer from: Radiation Oncologist at Academic Institution
Recommend 3000 cGy in 15 fractions
Sign in or Register to read more
808
Related Questions
What is your approach to managing follicular lymphoma with central nervous system involvement?
For a patient with ENKTL nasal type (nose/sinus involvement) who has hepatic toxicity with pegasparaginase but a CR after 2 cycles of chemotherapy with a plan for "sandwich" radiotherapy - what, if any, chemotherapy would you resume after completion of radiation?
For plasmablastic lymphoma responsive to treatment except for a recurrent lymph node eroding into a vertebral body at the end of chemotherapy, would you cover the entire vertebral body in your CTV, or treat only the involved lymph node with a margin?
Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
For patients with primary CNS lymphoma and less than a CR to chemotherapy, in what situation would you consider partial or focal radiation?
Is there a role for thiotepa-based auto transplant for consolidation in PCNSL if the patient had progression on both MTX and Ara-C?
How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
How do you approach frontline treatment for an elderly patient with adult T-cell leukemia-lymphoma (ATL)?